“Dapagliflozin in Heart Failure With Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness”. Journal of Pharmaceutical and Sciences, vol. 8, no. 4, Oct. 2025, pp. 2339-47, https://doi.org/10.36490/journal-jps.com.v8i4.1121.